Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
Bulletin Du Cancer
|
April 27, 2010
[Renal cell carcinoma management and therapies in 2010]
B Albouy, M Gross Goupil, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel and bone-targeted agents for CRPC
K Fizazi, L Albiges, C Massard, et al.
Bulletin Du Cancer
|
December 19, 2008
[Everolimus (RAD001) and solid tumours: a 2008 summary]
A Lévy, L Albiges Sauvin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
How to select amongst available options for the treatment of advanced RCC?
B Escudier, L Albiges, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2011
Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?
C Bourgier, C Massard, C Moldovan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
How to select targeted therapy in renal cell cancer
B Escudier, L Albiges, A Blesius, et al.
Bulletin Du Cancer
|
January 23, 2010
[Molecular targeted therapies in small-cell lung cancer]
A Levy, G G Malouf, B Besse, et al.
Bulletin Du Cancer
|
December 24, 2009
[Advances in adults' gliomas biology, imaging and treatment]
F Ducray, G Dutertre, D Ricard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2007
Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells
F Farace, C Massard, E Borghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2009
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
C Massard, J Zonierek, M Gross-Goupil, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
Bulletin Du Cancer
|
April 27, 2010
[Renal cell carcinoma management and therapies in 2010]
B Albouy, M Gross Goupil, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel and bone-targeted agents for CRPC
K Fizazi, L Albiges, C Massard, et al.
Bulletin Du Cancer
|
December 19, 2008
[Everolimus (RAD001) and solid tumours: a 2008 summary]
A Lévy, L Albiges Sauvin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
How to select amongst available options for the treatment of advanced RCC?
B Escudier, L Albiges, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2011
Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?
C Bourgier, C Massard, C Moldovan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
How to select targeted therapy in renal cell cancer
B Escudier, L Albiges, A Blesius, et al.
Bulletin Du Cancer
|
January 23, 2010
[Molecular targeted therapies in small-cell lung cancer]
A Levy, G G Malouf, B Besse, et al.
Bulletin Du Cancer
|
December 24, 2009
[Advances in adults' gliomas biology, imaging and treatment]
F Ducray, G Dutertre, D Ricard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2007
Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells
F Farace, C Massard, E Borghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 24, 2009
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
C Massard, J Zonierek, M Gross-Goupil, et al.
Page
of 9